Logo

American Heart Association

  142
  0


Final ID:

Discussant: CRRF-PEAF

  • Andrade, Jason  ( Vancouver General Hospital , Vancouver , British Columbia , Canada )
  • Author Disclosures:
    Jason Andrade: DO have relevant financial relationships ; Advisor:Boston Scientific:Active (exists now) ; Speaker:Abbott:Past (completed) ; Speaker:Biosense Webster:Past (completed) ; Advisor:Medtronic:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Revolutionizing AF Management: Cutting-Edge Approaches

Monday, 11/18/2024 , 09:45AM - 11:00AM

Late-Breaking Science

More abstracts on this topic:
Aggressive Risk factor REduction STudy for Atrial Fibrillation (ARREST-AF) implications for ablation outcomes: A Randomized Clinical Trial

Pathak Rajeev, Mahajan Rajiv, Abhayaratna Walter, Kalman Jonathan, Sanders Prashanthan, Elliott Adrian, Lau Dennis, Middeldorp Melissa, Linz Dominik, Fitzgerald John, Ariyaratnam Jonathan, Malik Varun, Noubiap Jean Jacques

Cryoballoon Ablation versus Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation (CRRF-PeAF): A Prospective, Multicenter, Randomized, Non-inferiority Clinical Trial

Miyamoto Koji, Fukaya Hidehira, Ashikaga Keiichi, Kobori Atsushi, Iwasaki Yuki, Murakami Masato, Satomi Kazuhiro, Yamauchi Yasuteru, Nitta Junichi, Takagi Masahiko, Kusano Kengo, Kanaoka Koshiro, Kishihara Jun, Sasaki Yasuhiro, Mizuno Shingo, Yamagami Shintaro, Yazaki Yoshinao, Nishiuchi Suguru, Kataoka Naoya

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available